Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESPECTS: Intensive BP Control for Recurrent Stroke Prevention
NCT01198496Phase 4Unknown
- Sponsor
- Biomedis Technologies Co.
- Start
- Oct 2010
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of losartan, hydrochlorothiazide, amlodipine, spironolactone in hypertension (HTN), sponsored by Biomedis Technologies Co.. Status: unknown.
02
Drugs
losartanhydrochlorothiazideamlodipinespironolactone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01198496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01198496.